What is Esperion Therapeutics's total revenue?

Esperion Therapeutics (ESPR) reported total revenue of $80.1M in Q1 2026.

How has Esperion Therapeutics's total revenue changed year-over-year?

Esperion Therapeutics's total revenue increased by 23.2% year-over-year, from $65M to $80.1M.

What is the long-term trend for Esperion Therapeutics's total revenue?

Over 4 years (2021 to 2025), Esperion Therapeutics's total revenue has grown at a 50.6% compound annual growth rate (CAGR), from $78.45M to $403.14M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Esperion Therapeutics ESPR Total Revenue

Total Revenue at other companies

AmgenAMGN

$8.62B+5.8%

Regeneron PharmaceuticalsREGN

$3.61B+19.0%

NewAmsterdam Pharma CompanyNAMS

$3.04M+2.1%

Lexicon PharmaceuticalsLXRX

$21.1M+1,572%

Eton Pharmaceuticals, Inc.ETON

$24.27M+40.4%

Zevra Therapeutics, Inc.ZVRA

$36.22M+77.5%

Segments

By product

See full

Collaboration revenue$36.71M+22.0%

Royalty Revenue From DSE And Sale Of Bulk Tablets And Milestones Received$32.7M+11.2%

Other financials

Income statement

See full

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

See full

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Reported directly by Esperion Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Esperion Therapeutics's total revenue?: Esperion Therapeutics (ESPR) reported total revenue of $80.1M in Q1 2026.
How has Esperion Therapeutics's total revenue changed year-over-year?: Esperion Therapeutics's total revenue increased by 23.2% year-over-year, from $65M to $80.1M.
What is the long-term trend for Esperion Therapeutics's total revenue?: Over 4 years (2021 to 2025), Esperion Therapeutics's total revenue has grown at a 50.6% compound annual growth rate (CAGR), from $78.45M to $403.14M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.